China Approves 17 Cancer Drugs for National Health Insurer

International Pharmaceutical Regulatory Monitor
A A
China’s State Medical Insurance Administration approved 17 cancer drugs for inclusion in the country’s national health insurance system with deeply discounted prices.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00